SCIENTIFIC HUB

Follow the evidence.

41.389 articles found

Source record

Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta-analysis of randomized controlled trials.

Yan R, Cai H, Cui Y, Su D, Cai G, Lin F, Feng T, Feng T.

Eur J Neurol · 2022-12-11

DOI: 10.1111/ene.15651PMID: 36437702

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

SLC39A14 Deficiency

Tuschl K, Gregory A, Meyer E, Clayton PT, Hayflick SJ, Mills PB, Kurian MA.

· 2022-12-08

PMID: 28541650

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Dopamine, Immunity, and Disease.

Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ.

Pharmacol Rev · 2022-12-08

DOI: 10.1124/pharmrev.122.000618PMID: 36757901

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

[Parkinson's disease].

Warnecke T, Lummer C, Rey JW, Claus I, Lüttje D.

Inn Med (Heidelb) · 2022-12-08

DOI: 10.1007/s00108-022-01444-3PMID: 36480073

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.